A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $322 to $383
Amgen Is Maintained at Neutral by UBS
Amgen Analyst Ratings
Goldman Sachs Adjusts Price Target on Amgen to $375 From $369, Maintains Buy Rating
A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $322 to $405
Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $362
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $335
Bernstein Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Navigating 14 Analyst Ratings For Amgen
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $383
Amgen Analyst Ratings
Goldman Sachs Maintains Amgen(AMGN.US) With Buy Rating
A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $335 to $381
DBS Maintains Amgen(AMGN.US) With Buy Rating
Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Jefferies Remains a Buy on Amgen (AMGN)
Amgen Analyst Ratings